Industry seeks clarity on FDA’s platform technology designation program
Regulatory NewsJoanne S. Eglovitch
Biologics License Application (BLA)Biologics/ biosimilars/ vaccinesBiotechnologyCBERCDERChemistry, Manufacturing and Controls (CMC)GuidanceManufacturingPharmaceuticalsProduct developmentRegulatory Intelligence/PolicyUnited States